Morpheus Research Uncovers Persistent Anti-Competitive Practices at MakeMyTrip Amidst Regulatory Challenges

Morpheus Research released a report accusing travel platform MakeMyTrip of ongoing anti-competitive practices despite a penalty from the Competition Commission of India in 2022. Allegations include price parity enforcement and accounting discrepancies. A new investigation by CCI is underway, with findings expected by early 2026.

Morpheus Research Uncovers Persistent Anti-Competitive Practices at MakeMyTrip Amidst Regulatory Challenges
This image is AI-generated and does not depict any real-life event or location. It is a fictional representation created for illustrative purposes only.
  • Country:
  • India

In a significant development, Morpheus Research has accused MakeMyTrip of continuing anti-competitive practices despite earlier regulatory penalties. Released on Monday, the report claims that MakeMyTrip is still enforcing price parity with hotel partners, disregarding a USD 26 million fine imposed by the Competition Commission of India (CCI) in 2022.

According to Morpheus Research, an activist short-seller with a disclosed short position in the company, the travel platform uses internal mechanisms such as a 'price competitiveness score' to maintain price parity indirectly. Adding to their concerns, the research highlights potential accounting irregularities and exposure to GoAir's insolvency.

Furthermore, Morpheus Research revealed that a new CCI investigation is set for 2026, casting a shadow over MakeMyTrip's operations. Despite MakeMyTrip's claims of compliance, Morpheus asserts that the company continues to defy regulatory orders, as supported by testimonies from industry experts and former employees.

Give Feedback